0.00
price down icon100.00%   -2.05
 
loading
Precedente Chiudi:
$2.05
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$116.14M
Reddito:
$1.50M
Utile/perdita netta:
$-64.59M
Rapporto P/E:
0.00
EPS:
-1.67
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
Value
$0.00
$0.00
Intervallo di 1 settimana:
Value
$0.00
$0.00
Portata 52W:
Value
$0.00
$2.54

Leap Therapeutics Inc Stock (LPTX) Company Profile

Name
Nome
Leap Therapeutics Inc
Name
Telefono
617 252 4343
Name
Indirizzo
47 THORNDIKE STREET, CAMBRIDGE, MA
Name
Dipendente
52
Name
Cinguettio
@LeapTherapeutic
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
LPTX's Discussions on Twitter

Compare LPTX vs VRTX, REGN, ALNY, ARGX, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
LPTX icon
LPTX
Leap Therapeutics Inc
0.00 116.14M 1.50M -64.59M -55.17M -1.67
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
454.00 115.33B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
732.87 77.48B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
312.17 41.40B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
663.93 41.09B 4.16B 1.29B 734.26M 19.59
ONC icon
ONC
Beone Medicines Ltd Adr
275.28 30.56B 5.36B 287.73M 924.18M 2.5229

Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-29 Downgrade H.C. Wainwright Buy → Neutral
2025-01-29 Downgrade Robert W. Baird Outperform → Neutral
2024-06-28 Iniziato Rodman & Renshaw Buy
2021-10-04 Iniziato Mizuho Buy
2021-06-04 Ripresa Robert W. Baird Outperform
2020-06-29 Iniziato Piper Sandler Overweight
2020-02-11 Iniziato Robert W. Baird Outperform
2019-11-15 Downgrade Raymond James Outperform → Mkt Perform
2019-09-13 Ripresa Raymond James Outperform
2017-03-07 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Leap Therapeutics Inc Borsa (LPTX) Ultime notizie

pulisher
Mar 18, 2026

Published on: 2026-03-19 01:39:58 - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

Can Leap Therapeutics Inc stock outperform in a bear marketWeekly Profit Recap & Fast Moving Trade Plans - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

Leap Therapeutics (LPTX) Stock Price, News & Analysis $LPTX - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Leap Therapeutics (NASDAQ:LPTX) Trading Up 368.6% – Still a Buy? - Defense World

Mar 17, 2026
pulisher
Mar 17, 2026

Cypherpunk Technologies Inc. (Formerly Leap Therapeutics) Combines Digital Privacy Tech and Cancer Drug Development – 2025 Annual Report Overview - Minichart

Mar 17, 2026
pulisher
Mar 17, 2026

LPTX SEC FilingsLeap Therapeutic 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 17, 2026
pulisher
Mar 02, 2026

Leap Therapeutics, Inc. Common Stock (CYPH) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Mar 02, 2026
pulisher
Mar 01, 2026

Leap Therapeutics, Inc.Common Stock (NQ: LPTX - The Chronicle-Journal

Mar 01, 2026
pulisher
Mar 01, 2026

Downgrade Watch: What is ONTOs TAM Total Addressable Market2025 Analyst Calls & Weekly Setup with High ROI Potential - baoquankhu1.vn

Mar 01, 2026
pulisher
Mar 01, 2026

Can Leap Therapeutics Inc deliver consistent dividendsMarket Activity Report & Capital Protection Trade Alerts - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 28, 2026

Aug Chart Watch: Can Leap Therapeutics Inc withstand a market correction2025 Institutional Moves & Daily Market Momentum Tracking - baoquankhu1.vn

Feb 28, 2026
pulisher
Feb 26, 2026

Momentum Shift: Whats the beta of Leap Therapeutics Inc stockQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn

Feb 26, 2026
pulisher
Feb 20, 2026

Big Money Moves: Is Sohucom Limited Depositary Receipt exposed to currency risksWeekly Gains Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

Can Leap Therapeutics Inc. deliver consistent dividendsStop Loss & AI Based Trade Execution Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Can Leap Therapeutics Inc. stock beat market expectations this quarterRecession Risk & AI Driven Stock Price Forecasts - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Can Leap Therapeutics Inc. (5MC) stock stage a strong rebound this quarterJuly 2025 Gainers & Precise Swing Trade Entry Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 17, 2026

Weekly Recap: Is Leap Therapeutics Inc a top pick in the sectorPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Feb 17, 2026
pulisher
Feb 05, 2026

Can Leap Therapeutics Inc withstand a market correctionJuly 2025 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn

Feb 05, 2026
pulisher
Jan 31, 2026

EV Market: Will Leap Therapeutics Inc outperform tech stocksMarket Risk Analysis & Accurate Intraday Trade Tips - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 31, 2026

Leap Therapeutics (NASDAQ:LPTX) versus Cyclacel Pharmaceuticals (NASDAQ:BGMS) Financial Contrast - Defense World

Jan 31, 2026
pulisher
Jan 26, 2026

Pharma News: Is Altisource Portfolio Solutions SA Equity Warrant being accumulated by smart moneyStop Loss & Safe Entry Trade Reports - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 24, 2026

Leap Therapeutics Stock More Than Doubles On Zcash Treasury Pivot – Former POTUS Advisor Calls It ‘Gangster’ Move - MSN

Jan 24, 2026
pulisher
Jan 24, 2026

Analyzing Leap Therapeutics (NASDAQ:LPTX) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World

Jan 24, 2026
pulisher
Jan 22, 2026

Earnings Beat: Can Leap Therapeutics Inc stock outperform in a bear market2025 Volatility Report & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 18, 2026

Exit Recap: Should I average down on PodcastOne Inc stockGap Down & Smart Investment Allocation Insights - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 18, 2026

Published on: 2026-01-18 21:43:08 - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 18, 2026

Critical Review: Pharmaxis (OTCMKTS:PXSLY) vs. Leap Therapeutics (NASDAQ:LPTX) - Defense World

Jan 18, 2026
pulisher
Jan 18, 2026

Leap Therapeutics Is Going Wild: Is LPTX The Next Biotech Moonshot Or Just Hype? - AD HOC NEWS

Jan 18, 2026
pulisher
Jan 17, 2026

Stock Recap: Can Leap Therapeutics Inc ride the EV waveEarnings Overview Report & High Yield Equity Trading Tips - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 17, 2026

Can Leap Therapeutics Inc disrupt its industry2025 Momentum Check & Community Shared Stock Ideas - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 13, 2026

US Market Wrap: How Leap Therapeutics Inc stock compares to growth peers2025 Market Overview & Verified Momentum Stock Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Institution Moves: Is Leap Therapeutics Inc. stock near bottom after declineWeekly Trade Review & Reliable Entry Point Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 09, 2026

How Leap Therapeutics Inc. stock performs after earningsTrail vs Road Selection & HOKA model picks for your routine - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

How Leap Therapeutics Inc. stock reacts to bond yieldsWeekly Market Outlook & Community Trade Idea Sharing - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How Leap Therapeutics Inc. stock reacts to job market dataNew Guidance & Expert Verified Stock Movement Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can Leap Therapeutics Inc. stock maintain operating marginsJuly 2025 Levels & Precise Swing Trade Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 03, 2026

CEO Moves: Will Leap Therapeutics Inc stock split attract more investorsDollar Strength & AI Driven Price Predictions - moha.gov.vn

Jan 03, 2026
pulisher
Dec 30, 2025

Gainers Report: Will Leap Therapeutics Inc stock split attract more investorsProduct Launch & AI Based Buy and Sell Signals - moha.gov.vn

Dec 30, 2025
pulisher
Dec 28, 2025

Reviewing Leap Therapeutics (NASDAQ:LPTX) and Vincerx Pharma (NASDAQ:VINC) - Defense World

Dec 28, 2025
pulisher
Dec 25, 2025

Published on: 2025-12-26 06:38:32 - moha.gov.vn

Dec 25, 2025
pulisher
Dec 21, 2025

Does Leap Therapeutics Inc. stock trade at a discount to peersGlobal Markets & Entry Point Strategy Guides - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Aug Decliners: Does Leap Therapeutics Inc. stock trade at a discount to peersEarnings Beat & Daily Oversold Stock Bounce Ideas - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Why Leap Therapeutics Inc. (5MC) stock is favored by hedge fundsQuarterly Investment Review & AI Based Buy and Sell Signals - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Is Leap Therapeutics Inc. stock near bottom after declineShare Buyback & Consistent Return Investment Signals - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Will Leap Therapeutics Inc. stock attract ESG investorsTrade Performance Summary & Reliable Entry Point Trade Alerts - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Why Leap Therapeutics Inc. stock is a must watch in 2025Weekly Profit Summary & Weekly Setup with High ROI Potential - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Leap Therapeutics Inc. stock a bargain at current levelsJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

VIX Spike: Does Leap Therapeutics Inc. stock trade at a discount to peersJuly 2025 Price Swings & Daily Momentum Trading Reports - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Merger Talk: Will Leap Therapeutics Inc. stock attract ESG investorsQuarterly Profit Report & Short-Term High Return Ideas - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Analyzing PaxMedica (NASDAQ:PXMD) and Leap Therapeutics (NASDAQ:LPTX) - Defense World

Dec 18, 2025
pulisher
Dec 15, 2025

Transcript : Leap Therapeutics, Inc.Shareholder/Analyst Call - marketscreener.com

Dec 15, 2025

Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Leap Therapeutics Inc Azioni (LPTX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
CAVANAUGH JAMES H
Director
Nov 17 '25
Sale
3.14
261,840
822,178
0
ONSI DOUGLAS E
CEO,CFO,Pres.,GC,Treas.&Sec.
Nov 17 '25
Sale
3.14
676,319
2,123,642
2,136
$45.36
price down icon 0.37%
$27.70
price down icon 0.36%
$51.38
price down icon 1.89%
$89.27
price down icon 0.04%
$136.00
price down icon 5.56%
ONC ONC
$275.28
price down icon 2.63%
Capitalizzazione:     |  Volume (24 ore):